GBCS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
GBCS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.
Selectis Health's Days Sales Outstanding for the
three
months ended in Dec. 2023 was 20.43.
Selectis Health's Days Inventory for the
three
months ended in Dec. 2023 was 0.
Selectis Health's Days Payable for the
three
months ended in Dec. 2023 was 61.64.
Therefore, Selectis Health's Cash Conversion Cycle (CCC) for the
three
months ended in Dec. 2023 was -41.21.
The historical data trend for Selectis Health's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Selectis Health's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Selectis Health's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Selectis Health's Cash Conversion Cycle falls into.
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Selectis Health's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as
Cash Conversion Cycle | = | Days Sales Outstanding | + | Days Inventory | - | Days Payable |
= | 25.93 | + | 0 | - | 56.36 | |
= | -30.43 |
Selectis Health's Cash Conversion Cycle for the quarter that ended in Dec. 2023 is calculated as:
Cash Conversion Cycle | = | Days Sales Outstanding | + | Days Inventory | - | Days Payable |
= | 20.43 | + | 0 | - | 61.64 | |
= | -41.21 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Selectis Health (OTCPK:GBCS) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Thank you for viewing the detailed overview of Selectis Health's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.
Lance Baller | director | 10173 BRIARGROVE WAY, HIGHLANDS RANCH CO 80126 |
David J. Furstenberg | director | 1226 WIND CHIME DR., WATERFORD MI 48327 |
Brandon Thall | officer: CFO | 8480 E. ORCHARD ROAD, STE. 4900, GREENWOOD VILLAGE CO 80111 |
Christopher R. Barker | officer: President and COO | 8480 E. ORCHARD ROAD, STE. 4900, GREENWOOD VILLAGE CO 80111 |
Neuman Clifford L Esq | director, 10 percent owner | 6800 NORTH 79TH STREET, SUITE # 200, NIWOT CO 80503 |
Downs John H Jr | director | PO BOX 723040, ATLANTA GA 30339 |
Andrew L Sink | director | P O BOX 531124, BIRMINGHAM AL 35253 |
Joshua Mandell | director | C/O GLOBAL HEALTHCARE REIT, INC., 8480 E. ORCHARD RD., STE. 4900, GREENWOOD VILLAGE CO 80111 |
Adam Desmond | director | PO BOX 2036, CARBONDALE CO 81623 |
Jacob Taylor | officer: Secretary | 6800 N. 79TH ST., STE. 200, NIWOT CO 80503 |
Sandra Lee Kuwica | officer: Vice President of Finance | C/O GLOBAL HEALTHCARE REIT, INC., 8480 E. ORCHARD RD., STE. 3600, GREENWOOD VILLAGE CO 80111 |
Steven Mark Bathgate | director | 5350 S ROSLYN, SUITE 380, ENGLEWOOD CO 80111 |
Philip S Scarborough | officer: Chief Financial Officer | 595 ATLANTA STREET, SUITE D, ROSWELL GA 30075 |
Christopher F Brogdon | director, officer: President | 2 BUCKHEAD PLAZA, 3050 PEACHTREE ROAD, SUITE 570, ATLANTA GA 30305 |
Brogdon Connie B | other: spouse of Director/President | 6000 LAKE FORREST DR, STE 200, ATLANTA GA 30328 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 01-11-2022
By Marketwired Marketwired • 08-20-2019
By Marketwired Marketwired • 05-20-2021
By Marketwired Marketwired • 05-21-2019
By Don Li2 Don Li2 • 11-12-2021
By Marketwired Marketwired • 09-21-2021
By Marketwired Marketwired • 11-01-2018
By PurpleRose PurpleRose • 07-11-2022
By Marketwired Marketwired • 11-18-2019
By GuruFocusNews GuruFocusNews • 04-20-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.